Buscar
Boston Scientific Corp
BSXAñadir a la lista de seguimiento
44.205USD
-0.255-0.57%
Cierre 06/25, 16:00（ET）Cotizaciones retrasadas 15 min
65.70BCap. mercado
18.39P/E TTM
Más Datos de Boston Scientific Corp Compañía
Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.
Información de Boston Scientific Corp
Símbolo de cotizaciónBSX
Nombre de la empresaBoston Scientific Corp
Fecha de salida a bolsaMay 19, 1992
Director ejecutivoMahoney (Michael F)
Número de empleados53000
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 19
Dirección300 Boston Scientific Way
CiudadMARLBOROUGH
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal01752-1234
Teléfono15086834000
Sitio Webhttps://www.bostonscientific.com/en-US/Home.html
Símbolo de cotizaciónBSX
Fecha de salida a bolsaMay 19, 1992
Director ejecutivoMahoney (Michael F)
Ejecutivos de Boston Scientific Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.86M
+0.66%
Mr. John E. Sununu
Mr. John E. Sununu
Independent Director
Independent Director
54.72K
--
Mr. Vance R. Brown
Mr. Vance R. Brown
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
54.24K
--
Mr. David S. (Dave) Wichmann
Mr. David S. (Dave) Wichmann
Independent Director
Independent Director
45.38K
+8.37%
Mr. Jonathan R. Monson
Mr. Jonathan R. Monson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
37.99K
--
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Director
Independent Director
27.93K
+13.60%
Mr. David C. Habiger
Mr. David C. Habiger
Independent Director
Independent Director
13.88K
+59.45%
Mr. Yoshiaki Fujimori
Mr. Yoshiaki Fujimori
Independent Director
Independent Director
2.08K
--
Mr. Joseph M. Fitzgerald
Mr. Joseph M. Fitzgerald
Executive Vice President, Group President - Cardiology
Executive Vice President, Group President - Cardiology
--
--
Mr. Edward J. Ludwig
Mr. Edward J. Ludwig
Lead Independent Director
Lead Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.86M
+0.66%
Mr. John E. Sununu
Mr. John E. Sununu
Independent Director
Independent Director
54.72K
--
Mr. Vance R. Brown
Mr. Vance R. Brown
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
54.24K
--
Mr. David S. (Dave) Wichmann
Mr. David S. (Dave) Wichmann
Independent Director
Independent Director
45.38K
+8.37%
Mr. Jonathan R. Monson
Mr. Jonathan R. Monson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
37.99K
--
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Director
Independent Director
27.93K
+13.60%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Boston Scientific Corp?
Los cinco principales accionistas de Boston Scientific Corp son: Mr. Michael F. (Mike) Mahoney
¿Cuántas instituciones poseen acciones de Boston Scientific Corp (BSX)?
A fecha de 2026Q1, 3113 instituciones poseen acciones de Boston Scientific Corp, con un valor de mercado combinado de aproximadamente 1.40B, lo que representa el 94.35% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -15512534.00.
¿Cuál es la mayor fuente de ganancias de Boston Scientific Corp?
El 2026Q1, el segmento empresarial Interventional Cardiology Therapies generó la ganancia más alta para Boston Scientific Corp, ascendiendo a 4.64B y representando el 23.11% de la ganancia total.
